EUCTR2016-000354-35-DKActive, not recruitingPhase 1
High dose antioxidant treatment of patients with cystic fibrosis evaluated by measuring desmosine/isodesmosine in urine
Aarhus University Hospital0 sitesStarted: February 10, 2016Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Cystic fibrosis genotype and FVC above 40 %
- •Clinically stable patients
- •NO antibiotics or antiinflammatory treatment prior to or under trial
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 30
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Unstable clinical condition
- •Unable to perform reliable LFT
Investigators
Similar Trials
Active, not recruiting
Phase 1
High Dose Antioxidant Treatment for Patients with Cystic FibrosisCystic FibrosisEUCTR2013-005481-19-DKAarhus University Hospital
Not yet recruiting
Phase 4
Oral medication for PyorrhoeaCTRI/2019/05/019281Triveni Institute of Dental Sciences
Not yet recruiting
Phase 3
A clinical trial to study the effect of antioxidants in the management of temporomandibular disordersCTRI/2022/04/042337Dr Pavithra M
Not yet recruiting
Phase 3
Impact of antioxidant cocktail in transfusion dependent beta thalassemiaCTRI/2024/06/068355Arti Purohit
Recruiting
Phase 2
High dose vitamin C as an adjuvant therapy in patient with septic shockPatient with septic shockseptic shock,vitamin c,ascorbic acidTCTR20180925004Bhumibol Adulyadej Hospital Fund60